In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
skip over navigation
Print
PRINT  
Email
EMAIL

News from UT Southwestern

Health Tips
Health News Tips

More Information

Dotted Line

UT Southwestern
Medical Center Newsroom

Dotted Line

To access the Medical Center Newsroom, including news staff and media contact information, please click here.

Looking for
Archived News?

Dotted Line

For all archived news, please click here.

News Story Links

Dotted Line

Mitigating migraine pain

  

When conventional therapies for migraine don’t work, new research shows surgical options can have a lasting effect.

Dr. Jeffrey Janis, a plastic surgeon at UT Southwestern Medical Center, helped develop a technique that uses Botox – typically known for cosmetic uses – to help identify potential peripheral nerve trigger points that may be contributing to migraine pain. He also was involved in developing surgical techniques based on anatomical studies to decompress these nerves in order to provide more long-lasting relief.

In a recently published study, Dr. Janis corroborated the effectiveness of using Botox and surgery to treat migraine headaches. He confirmed the use of Botox led to average improvement of 85.5 percent over original symptoms such as frequency, severity, duration, while surgery produced an astounding 96.6 percent average improvement over original symptoms. A separate five-year review verified that the surgical treatments for migraines had lasting effects.

“This type of surgery is not for everyone, but for those who have not found relief, these procedures are proving effective,” Dr. Janis notes.

For information on cosmetic surgery procedures and clinical services at UT Southwestern, visit www.utsouthwestern.org/plasticsurgery or call 214-645-8300.

Media Contact: Russell Rian

Drop Shadow